Pilot Window of Opportunity Trial (POET)

Summary

The proposed clinical trial with TPST-1495 can help people with two types of cancer, Endometrial Cancer (EC) and Colorectal Carcinoma (CRC), who need surgery. The investigator plans to evaluate how well TPST-1495 works against these cancers by checking blood samples and tumor tissues taken before and after the treatment to see if it is an effective treatment option to help the immune system fight against cancer.

Timeline

Start

2024-04-03

Primary completion

2025-08-22

Completion

2026-09-30

Drugs

Indications